Dimethyl fumarate associated lymphopenia in clinical practice

被引：34
|
作者：
Longbrake, Erin E. [1 ]
Cross, Anne H. [1 ]
机构：
[1] Washington Univ, Dept Neurol, St Louis, MO 63110 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷 / 06期
关键词：
Dimethyl fumarate; multiple sclerosis; lymphopenia; PLACEBO-CONTROLLED PHASE-3; MULTIPLE-SCLEROSIS; ORAL BG-12; PML;
D O I：
10.1177/1352458514559299
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：796 / 797
页数：2
相关论文
共 50 条
  • [41] Dimethyl fumarate treatment produces alterations in lipid metabolism that are linked to occurrence of lymphopenia
    Bhargava, Pavan
    Fitzgerald, Kathryn
    Smith, Matthew
    Kornberg, Michael
    Mowry, Ellen
    Calabresi, Peter
    NEUROLOGY, 2017, 88
  • [42] Dimethyl Fumarate in Relapsing Remitting Multiple Sclerosis: Effects of Dose Reduction on Lymphopenia
    Wong, Ka-Ho
    Marini, Erica
    Clardy, Stacey
    DeWitt, L.
    Klein, Julia
    Soldan, M. Paz
    Rose, John
    NEUROLOGY, 2017, 88
  • [43] Systematic Evaluation of Dimethyl Fumarate induced Lymphopenia in Multiple Sclerosis (MS) Patients
    Malik, Muhammad Taimur
    Zhang, Yanfei
    Lee, Ming
    NEUROLOGY, 2021, 96 (15)
  • [44] Delayed and recurrent dimethyl fumarate induced-lymphopenia in patients with multiple sclerosis
    Borrelli, S.
    Mathias, A.
    Le Goff, G.
    Du Pasquier, R.
    Theaudin, M.
    Pot, C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 63
  • [45] Dimethyl fumarate-associated PML
    Reactions Weekly, 2015, 1551 (1) : 1 - 1
  • [46] Clinical characteristics of relapsing-remitting multiple sclerosis patients with persistent lymphopenia with dimethyl fumarate and comparison with no lymphopenic patients
    Lopez Ruiz, R.
    Eichau, S.
    Perez Gamez, M.
    Navarro Mascarell, G.
    Ruiz-Pena, J. L.
    Paramo Camino, M. D.
    Izquierdo, G.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 921 - 922
  • [47] Dimethyl Fumarate-Associated Enterocolitis
    Bajwa, Numra A.
    Bajwa, Azka A.
    Ghazala, Seham
    Masood, Umair
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (04) : e448 - e450
  • [48] Predictive factors of lymphopenia in a young cohort of Multiple Sclerosis patients treated with Dimethyl Fumarate
    Krupka, Danna
    Ferreira, Vitor Mendes
    Correia, Ana Sofia
    Teixeira, Manuel Salavisa
    Serrazina, Filipa
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 971 - 971
  • [49] Relationship between lymphopenia and disease activity in persons with multiple sclerosis treated with dimethyl fumarate
    Chu, Laura
    Balusha, Abedallah
    Casserly, Courtney
    Berger, Warren
    Morrow, Sarah A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [50] Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis
    Ravn, Julie
    Jensen, Henrik Boye
    Kant, Matthias
    Andersen, Preben Borring
    Gora, Monika Katarzyna
    Sejbaek, Tobias
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
12345